1. Home
  2. OMDA vs ESPR Comparison

OMDA vs ESPR Comparison

Compare OMDA & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OMDA

Omada Health Inc.

HOLD

Current Price

$11.32

Market Cap

897.6M

Sector

Health Care

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.43

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMDA
ESPR
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
897.6M
793.7M
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
OMDA
ESPR
Price
$11.32
$3.43
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$24.80
$6.67
AVG Volume (30 Days)
1.3M
4.4M
Earning Date
03-05-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$232,342,000.00
$303,802,000.00
Revenue This Year
$52.49
$27.49
Revenue Next Year
$22.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
89.23
2.83
52 Week Low
$10.28
$0.69
52 Week High
$28.40
$4.18

Technical Indicators

Market Signals
Indicator
OMDA
ESPR
Relative Strength Index (RSI) 25.95 49.78
Support Level $10.28 $3.16
Resistance Level $12.05 $3.52
Average True Range (ATR) 1.05 0.19
MACD -0.31 0.02
Stochastic Oscillator 14.38 53.12

Price Performance

Historical Comparison
OMDA
ESPR

About OMDA Omada Health Inc.

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: